Biotechnology Pharmaceutical October 29, 2026 Petosemtamab Phase 3 Results: Genmab Head and Neck Cancer Drug Cuts Death Risk 50% With Keytruda
Health October 29, 2026 CDC Antimicrobial Resistance Report: Drug-Resistant Germs Cause About 51,000 U.S. Deaths a Year
World News October 27, 2026 Brazil Election Results: Lula Wins Fourth Term as Bolsonaro’s Party Concedes and Flávio Bolsonaro Surrenders Passports
AI & Machine Learning Technology October 27, 2026 Anthropic IPO Filing: S-1 Reveals $16.3 Billion in Half-Year Revenue, $80.7 Billion Loss and AI Safety Risks
Company Alerts NYSE-NASDAQ October 26, 2026 Stock Market Outlook: Futures Rise as Oil Eases After Houthi Strikes on Saudi Targets; Fed and Big Tech Earnings Loom
Biotechnology Pharmaceutical October 29, 2026 Petosemtamab Phase 3 Results: Genmab Head and Neck Cancer Drug Cuts Death Risk 50% With Keytruda
Biotechnology Pharmaceutical October 29, 2026 Petosemtamab Phase 3 Results: Genmab Head and Neck Cancer Drug Cuts Death Risk 50% With Keytruda
Health October 29, 2026 CDC Antimicrobial Resistance Report: Drug-Resistant Germs Cause About 51,000 U.S. Deaths a Year
World News October 27, 2026 Brazil Election Results: Lula Wins Fourth Term as Bolsonaro’s Party Concedes and Flávio Bolsonaro Surrenders Passports
AI & Machine Learning Technology October 27, 2026 Anthropic IPO Filing: S-1 Reveals $16.3 Billion in Half-Year Revenue, $80.7 Billion Loss and AI Safety Risks
